StreetAlpha.app
Home › Stocks › RVMD

Revolution Medicines, Inc. (RVMD)

Healthcare
$162.69
▼ −2.50%
LAST CLOSE · NOV 17

Revolution Medicines develops cancer drug candidates from its base in Redwood City, California. It last closed at $162.69 on Nov 17, down 2.50% on the day. RVMD last reported earnings on Wed, Nov 4, 2026. The average 12-month price target from 17 analysts is $270.18 (+66.1% from the last close), with a high of $350.00 and a low of $179.00. Analyst consensus is Strong Buy, based on the latest ratings from 17 firms (16 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 4 whale options trades in RVMD, 25% of them bullish and 75% bearish. In the past 30 days there were 16 dark pool prints totaling $15.2M, the largest $2.6M.

AI Auto Pilots
Is RVMD in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$197.6M
Net income
−$1.9B
−946.8% margin
EPS (diluted)
−$9.13
Free cash flow
−$1.4B
−729.3% margin
Valuation
Market cap
$35.2B
216.3M shares
P/E
–
No P/E while losing money
Price to sales
178.1
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$615.9M
At Sep 30
Debt
$487.9M
At Sep 30
Shareholder equity
$2.4B
Shares outstanding
216.3M
At Oct 30
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $29.4M$29.4MFY2021FY2022: $35.4M$35.4MFY2022FY2023: $11.6M$11.6MFY2023FY2024: $0$0FY2024FY2025: $0$0FY2025

From RVMD's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 4). Last 12 months adds up the four latest quarters.

Last report
Nov 4
2026 · After the close (AMC)
Reported EPS
-$1.90
vs -$2.34 est. · beat
Year-ago EPS
—
Not on file
Options-implied move
±9.6%
Priced in before that report
Analyst consensus
Strong Buy
Based on 17 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
17firms
16 Buy1 Hold0 Sell
Each firm's latest rating on RVMD in the past 90 days
Average 12-month target
$270.18
▲ 66.1% upside

Based on 17 analysts who set a price target on RVMD in the past 90 days. The average target is $270.18, with a high of $350.00 and a low of $179.00, compared with the last close of $162.69.

$134$211$289$366PAST 15 TRADING DAYS12-MONTH TARGETSHIGH $350AVG $270.18LOW $179May 22LAST CLOSE+12 MO$134$211$289$366PAST 15 DAYSTARGETSHIGH $350AVG $270.18LOW $179May 22LAST CLOSE+12 MO
Highest target$350.00
Average target$270.18
Lowest target$179.00
Latest rating changes
Morgan StanleyTarget lowered
Nov 13Buy$255 → $247
HC Wainwright & Co.Target raised
Nov 6Buy$280 → $350
TD CowenTarget raised
Nov 5Buy$250 → $270
RBC CapitalTarget raised
Nov 5Buy$260 → $321
Piper SandlerMaintained
Nov 5Buy$222
DateFirmActionRatingPrice target
Nov 13Morgan StanleyTarget loweredBuy$255 → $247
Nov 6HC Wainwright & Co.Target raisedBuy$280 → $350
Nov 5TD CowenTarget raisedBuy$250 → $270
Nov 5RBC CapitalTarget raisedBuy$260 → $321
Nov 5Piper SandlerMaintainedBuy$222
Loading…

Technical Analysis

RVMD · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend, nearing oversold

The stock is 14% below its 20 day and 18% below its 50 day average. It is 1% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 35), near oversold. The nearest support is the 200 day average at $160.55, and the nearest resistance the Pivot at $164.12.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityHigh, 5.9%/day
Key levels
$224.3152 week high+37.9%
$195.00100 day average+19.9%
$192.7150 day average+18.5%
$185.6820 day average+14.1%
$166.56Pivot R1+2.4%
$166.50Swing high (Jun 1)+2.3%
$164.12Pivot+0.9%
$162.69Last close
$160.55200 day average−1.3%
$160.26Pivot S1−1.5%
$149.10Swing low (May 28)−8.4%
$67.2752 week low−58.7%
Indicators
RSI (14)35.40Weak, oversold below 30Neutral
MACD-6.02Below its signal lineBearish
Stochastic4.4Near the bottom of its rangeOversold
ADX (14)20.7Weak trend
Williams %R-97.9Oversold below −80, overbought above −20Oversold
CCI (20)-220.3Oversold below −100, overbought above 100Oversold
Rate of change−16.2%Change over 10 sessionsBearish
ATR (14)$9.55Typical daily range, 5.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for RVMD

What happened before

See how RVMD did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Whale flow leans bearish1 bullish and 3 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow RVMD usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How RVMD has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
4
Bullish
1
25%
Bearish
3
75%
Date span
Aug 24 – Oct 16
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
16
Notional
$15.2M
Largest print
$2.6M
Loading…

RVMD Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▲453 buying vs 269 selling
  • ▼Held by funds -1.0 pts
  • ▲Funds holding +62
  • ▲Superinvestors: 3 added, 1 cut
  • ▼Put/call 0.52 to 1.13
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding757695+8.9%
In funds' top 103747−21.3%
Held by funds98.1%99.1%−1.0 pts
New / increased141 / 312237 / 243−5.6%
Reduced / sold out197 / 72148 / 64+26.9%
Put/call ratio1.130.52+115.2%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See RVMD institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RVMD is in one of them and how their past RVMD trades turned out.

RVMD in the AI portfolios
Loading…

RVMD News & Analysis

All StreetAlpha news →
RVMD in the news

RVMD Congress Trades

All congress trades →
Trades, 12 months
4
Buys
2
50%
Sells
2
50%
People
2
Last filed Sep 30
Who traded RVMD · since 2026
Latest 4 filings
$1K – $15KTraded Jul 30, 2026Filed Sep 30, 2026
$1K – $15KTraded Jul 17, 2026Filed Sep 22, 2026
$50K – $100KTraded May 18, 2026Filed Jul 1, 2026
$1K – $15KTraded Mar 23, 2026Filed May 14, 2026
PersonTypeAmountTradedFiledDelay
Scott A KuporExecutive branchSell$1K – $15KJul 30, 2026Sep 30, 202662 d
Donald J TrumpExecutive branchBuy$1K – $15KJul 17, 2026Sep 22, 202667 d
Donald J TrumpExecutive branchSell$50K – $100KMay 18, 2026Jul 1, 202644 d
Donald J TrumpExecutive branchBuy$1K – $15KMar 23, 2026May 14, 202652 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Revolution Medicines

Revolution Medicines is a biotechnology company based in Redwood City, California. It is developing drug candidates for cancer, including RAS(ON) inhibitors, which are being tested alone and in combination with other cancer therapies. None of its product candidates has received regulatory approval yet, so it does not currently sell products. Its work is aimed at cancer patients and the doctors who treat them.

Headquarters
Redwood City, CA
Founded
2014